Published in Clinical Oncology Week, November 21st, 2005
According to recent research from the United States, "We detected circulating PCs by flow cytometry in 302 patients with newly diagnosed MM by gating on CD38+CD45- cells. The number of circulating PCs per 50,000 mononuclear cells was reported."
"In 80 (27%) patients, no circulating PC were seen; 106 (35%) patients had 1 to 10 and 115 (38%) patients had more than 10 circulating PCs. Median overall survival for the 302 patients was 47 months. Patients with 10 or fewer circulating PCs had a median survival of 58.7...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.